Exact Mass: 433.2593110000001

Exact Mass Matches: 433.2593110000001

Found 500 metabolites which its exact mass value is equals to given mass value 433.2593110000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

f-NLP-ME

N-Formyl-norleucyl-leucyl-phenylalanyl-methylester

C23H35N3O5 (433.25765800000005)

Paspalinine

5b-hydroxy-2,2,13b,13c-tetramethyl-2,3,5b,6,7,7a,8,13,13b,13c,14,15-dodecahydro-4h-3,15a-epoxy[1]benzoxepino[6,7:6,7]indeno[1,2-b]indol-4-one

C27H31NO4 (433.22529660000004)

Hericenone B

6-[(2Z)-3,7-dimethyl-5-oxoocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-2,3-dihydro-1H-isoindol-1-one

C27H31NO4 (433.22529660000004)

Hericenone B is found in mushrooms. Hericenone B is isolated from the edible lions mane mushroom (Hericium erinaceum). Isolated from the edible lions mane mushroom (Hericium erinaceum). Hericenone B is found in mushrooms.

N-Arachidonoyl Glutamic acid

2-[(1-Hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]pentanedioate

C25H39NO5 (433.2828084)

N-arachidonoyl glutamic acid, also known as N-arachidonoyl glutamate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Glutamic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Glutamic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Glutamic acid is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

N-Eicosapentaenoyl Methionine

2-(icosa-5,8,11,14,17-pentaenamido)-4-(methylsulfanyl)butanoic acid

C25H39NO3S (433.26505040000006)

N-eicosapentaenoyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Methionine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

Acridine, 3,6-bis(2-(1-piperidinyl)ethoxy)-

3,6-Bis(2-piperidinoethoxy)acridine trihydrochloride

C27H35N3O2 (433.272913)

Mofarotene

4-(2-{4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]phenoxy}ethyl)morpholine

C29H39NO2 (433.2980634)

Ulipristal

17-Acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

C28H35NO3 (433.26168000000007)

Ilicicolin H

C27H31NO4 (433.22529660000004)

An aromatic ketone in which the ketone carbonyl group is attached to a (1R,2R,4aS,7S,8aR)-4,7-dimethyl-1-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-yl group and a 4-hydroxy-5-(4-hydroxyphenyl)-2-oxo-1,2-dihydropyridin-3-yl group. Isolated from the from the "imperfect" fungus Cylindrocladium iliciola strain MFC-870.

Isohypognavine

Isohypognavinol 2-benzoate

C27H31NO4 (433.22529660000004)

Aspochalasin K

C25H39NO5 (433.2828084)

Deacetylhanamisine

C27H31NO4 (433.22529660000004)

15-Benzoylpseudokobusine

Ser Val Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]-3-hydroxybutanamido]hexanoic acid

C18H35N5O7 (433.25363600000003)

Thr Lys Trp

C21H31N5O5 (433.2325076)

Ile Ser Gly Ala Ser

C17H31N5O8 (433.2172526)

tryptophylthreonyllysine

C21H31N5O5 (433.2325076)

lysylmethionylarginine

C17H35N7O4S (433.2471110000001)

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]propanamido]hexanoic acid

C18H35N5O5S (433.23587800000007)

Ile Cys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]hexanamido]propanoic acid

C18H35N5O5S (433.23587800000007)

(4S)-4-[({[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}methyl)carbamoyl]-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C17H31N5O8 (433.2172526)

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]hexanamido]propanoic acid

C18H35N5O5S (433.23587800000007)

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C17H31N5O8 (433.2172526)

Lys Trp Thr

C21H31N5O5 (433.2325076)

Met Arg Lys

C17H35N7O4S1 (433.2471110000001)

Met Gly Lys Val

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}hexanamido]-3-methylbutanoic acid

C18H35N5O5S (433.23587800000007)

Met Gly Val Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-methylbutanamido]hexanoic acid

C18H35N5O5S (433.23587800000007)

Met Lys Gly Val

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]acetamido}-3-methylbutanoic acid

C18H35N5O5S (433.23587800000007)

Met Lys Val Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-methylbutanamido]acetic acid

C18H35N5O5S (433.23587800000007)

Met Val Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylbutanamido]acetamido}hexanoic acid

C18H35N5O5S (433.23587800000007)

Met Val Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylbutanamido]hexanamido]acetic acid

C18H35N5O5S (433.23587800000007)

Met Lys Arg

C17H35N7O4S1 (433.2471110000001)

Cys Arg Arg

C15H31N9O4S1 (433.22196060000005)

Arg Lys Met

C17H35N7O4S1 (433.2471110000001)

Arg Arg Cys

C15H31N9O4S1 (433.22196060000005)

Lys Thr Trp

C21H31N5O5 (433.2325076)

Arg Cys Arg

C15H31N9O4S1 (433.22196060000005)

Thr Trp Lys

C21H31N5O5 (433.2325076)

Arg Ala Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C16H31N7O7 (433.2284856)

Arg Ala Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C16H31N7O7 (433.2284856)

Arg Gly Thr Thr

(2S,3R)-2-[(2S,3R)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-hydroxybutanamido]-3-hydroxybutanoic acid

C16H31N7O7 (433.2284856)

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C16H31N7O7 (433.2284856)

Thr Ala Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C16H31N7O7 (433.2284856)

6-[(2Z)-3,7-dimethyl-5-oxoocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-2,3-dihydro-1H-isoindol-1-one

C27H31NO4 (433.22529660000004)

(7E)-11,12-Dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

C25H39NO5 (433.2828084)

NA 25:6;O4

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glutamic acid

C25H39NO5 (433.2828084)

Aplidic acid C

(E)-6-[(3aR,4R,5R,7aS)-4-[(1E,3E)-5-oxo-5-(2-phenylethylamino)penta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]hex-5-enoic acid

C28H35NO3 (433.26168000000007)

NA 28:11;O2

Ulipristal

C28H35NO3 (433.26168000000007)

G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XB - Progesterone receptor modulators G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AD - Emergency contraceptives C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist